methylprednisolone hemisuccinate has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gluck, C; Hooper, DK; Koziell, A; Moodalbail, D; Okamura, D; Shah, L; Wallace, D; Zaritsky, JJ | 1 |
1 other study(ies) available for methylprednisolone hemisuccinate and Focal Segmental Glomerulosclerosis
Article | Year |
---|---|
LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
Topics: Allografts; Blood Component Removal; Child; Child, Preschool; Combined Modality Therapy; Creatinine; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Humans; Infant; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Lipoproteins, LDL; Male; Methylprednisolone Hemisuccinate; Proteinuria; Pulse Therapy, Drug; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome | 2019 |